- NEO PERFORMANCE MATERIALS INC. <NEO.TO>: STIFEL RAISES TARGET PRICE TO C$55 FROM C$49
- SUPER MICRO COMPUTER INC <SMCI.O>: RAYMOND JAMES RAISES TARGET PRICE TO $48 FROM $39
- BLACK ROCK COFFEE BAR, INC. <BRCB.O>: RAYMOND JAMES CUTS TARGET PRICE TO $13 FROM $18
- Alterity wins new US composition-of-matter patent for ATH434, extending protection to 2045
- Rubicon Organics Q2 revenue rises on yield gains at Pacifica facility
- SUPER MICRO COMPUTER INC <SMCI.O>: ROSENBLATT SECURITIES RAISES TARGET PRICE TO $51 FROM $45
- Rising energy prices disrupt the bond market, with UK bonds showing high sensitivity to oil prices
- Spot platinum has just surpassed the $1,780.00/oz mark, currently trading at $1,780.05/oz, up 2.15% on the day; Nymex platinum futures main contract is now quoted at $1,792.5/oz, up 2.14% on the day.
- South Korea Tightens Oversight of Crypto Market Transactions
- Kamada FY26 H1 net income rises 18.11% to $13.39 million; revenue climbs 12.83% to $100.16 million
- Cypherpunk Q2 FY26 net income swings to $39.4 million; operating loss narrows to $4.69 million
- LUMENTUM HOLDINGS INC. <LITE.O>: RAYMOND JAMES RAISES TARGET PRICE TO $1036 FROM $1014
- RedCloud signs India MOUs with Dheer Marketing, Klakshya to deploy RedAI across apparel distribution
- SUNation Q2 FY26 net loss narrows 65% to $3.34 million; revenue drops 37.5% to $8.2 million
- White Gold held shareholder meeting on W2 Critical Minerals spinout approval
- Athena Gold says partner Mammoth hits shallow gold at Excelsior Springs project in Nevada
- Perma-Fix wins Hanford tank waste grouting, disposal IDIQ subcontract with $4.37 billion ceiling
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- Metro FY26 Q3 net earnings drop 34.6% to $211.3 million; sales rise 1.4% to $6.97 billion
- Milestone Pharmaceuticals 2Q Loss/Shr 21c >MIST
- Milestone Pharmaceuticals 2Q Rev $559,000 >MIST
- HLS Therapeutics Q2 2026 revenue rises 3.5% as company cites Vascepa sales growth, first full quarter of NILEMDO sales
- Can-Fite says Phase III namodenoson trial in advanced liver cancer advances under FDA, EMA guidance
- Avino Q2 FY26 net income more than doubled to US$10.9 million; revenue rises 23% to US$26.8 million
- Milestone Pharmaceuticals Q2 FY26 net loss widens 120.7% to $28.61 million
- Milestone Pharmaceuticals 2Q Loss $28.6M >MIST
- Marex Q2 FY26 profit after tax more than doubles to $155.3 million; revenue rises 39% to $695.8 million
- LUMENTUM HOLDINGS INC. <LITE.O>: BOFA GLOBAL RESEARCH CUTS PRICE OBJECTIVE TO $1000 FROM $1100
- Torrent Capital Q2 FY26 net income more than doubles to $4.7 million; NAV rises to $33.1 million
- MARRIOTT VACATIONS WORLDWIDE <VAC.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $134 FROM $119
- Rocky Shore Gold starts drilling Mosquito Target Horizon at Gold Anchor project in Newfoundland
- First Mining Gold announces Q2 2026 financial results, MD&A posted
- Invesque 2Q Rev $2.7M >IVQ.T
- JPMorgan announces JPST monthly cash distribution of $0.07 per unit on TSX-listed ETF
- Humacyte Q2 FY26 net loss narrows to $36.8 million; Symvess revenue more than quadruples to $406,000
- Easor to release half-year financial report in webcast briefing
- Kornit Digital Q2 FY26 GAAP net loss widens 48.6% to $11.2 million; revenue rises 11.2% to $55.3 million
- Conquest Resources reports 15.31 g/t gold over 3 m at Smith Lake project in Ontario
- Acumen Q2 FY26 net loss narrows to $32.7 million; R&D expenses fall to $27.8 million
- WeRide 2Q FY26 loss narrows 1.4% YoY to RMB 400.7 million; revenue rises 82.2% YoY to RMB 231.7 million
- TScan Q2 FY26 net loss narrows to $30.4 million; revenue drops to $1.1 million
- WhiteFiber 2Q Loss/Shr 39c >WYFI
- TScan Therapeutics 2Q Research and Development Expenses $23.4M >TCRX
- Metro Inc: Opened Five Stores In 3Q >MRU.T
- Acumen Pharmaceuticals 2Q Loss/Shr 45c >ABOS
- Trustar Bankshares begins trading on OTCQX Best Market under TRSB, OTC Markets says
- Fervo Q2 FY26 net loss widens to $55.9 million; revenue rises to $113,000
- Bausch + Lomb names Thomas Appio board chair in amended filing, replacing Brent Saunders
- FirstService Residential wins management contract for Sea Colony East Phase III condo in Delaware
- Pandox signs long-term revenue-based lease with Strawberry for Bodø hotel property
- Sutro Biopharma Q2 FY26 net loss widens to USD 38.53 million; revenue drops to USD 9.84 million
- WhiteFiber FY26 Q2 net loss widens to USD 15 million; revenue rises 54% to USD 28.8 million
- Update for XRP Holders: Lummis States What Will Happen If CLARITY Act Is Killed
- Lighthouse Canton says defense, hard-asset pullback signals regroup, not retreat
- Defense Metals invited to seek up to C$32 million NRCan funding for Wicheeda rare earth processing program
- SUNation Energy 2Q Sales $8.16M >SUNE
- Definium Therapeutics says Phase 3 Voyage trial meets primary endpoint for DT120 ODT in generalized anxiety disorder
- Similarweb Q2 FY26 GAAP operating income swings to USD 0.7 million; revenue rises 9% to USD 77.2 million
- Sound Point Meridian fee waiver cuts base management fee to 1.5%, incentive fee to 15% through Dec. 31, 2026
- Kamada CFO Chaime Orlev to step down effective Dec. 31, 2026
- Sound Point Meridian Capital declares USD 0.13 monthly common distribution for October-December 2026
- CARDIFF ONCOLOGY, INC. <CRDF.O>: WILLIAM BLAIR CUTS TO MARKET PERFORM RATING
- PFG FY26 Q4 GAAP net income rises 23.4% to $162.3 million; net sales climb 6.4% to $18 billion
- Aclarion says USPTO issues notice of allowance for lumbar disc MRS scan-prescription patent application
- Octave Q2 FY26 net loss widens to $1.97 billion; revenue falls 4% y/y to $398 million
- LENZ THERAPEUTICS, INC. <LENZ.O>: CITIGROUP CUTS TARGET PRICE TO $10 FROM $20
- UnitedHealth Group declares cash dividend of $2.32 a share
- Lexeo net loss narrows to $25.9 million in Q2 FY26; R&D expenses rise to $19 million
- Chiron Real Estate director Charles Fitzgerald reports acquisition of 27,600 common shares valued at $992,944
- Mercia Fund Management cuts Northern 3 VCT annual fee to 2% of NAV from Oct. 1
- D-Wave wins up to CAD 300,000 NRC funding for annealing quantum software development
- Harvia updates financial calendar for 2027 reporting schedule
- Northern 3 VCT cuts Mercia annual management fee to 2% of NAV from Oct 1, 2026
- BRIEF-Metro Inc Q3 Adjusted EPS CAD 1.24 Vs. IBES Estimate CAD 1.24
- BRIEF-Avino Q2 Adjusted EPS USD 0.06
- BRIEF-Humacyte Q2 Operating Expenses USD 27.402 Million
- BRIEF-Sutro Biopharma Q2 Revenue USD 9.839 Million Vs. IBES Estimate USD 13 Million
- BRIEF-Performance Food Q4 Adjusted EPS USD 1.59 Vs. IBES Estimate USD 1.6
- BRIEF-Rubicon Organics Q2 Revenue CAD 18.5 Million
- BRIEF-Acumen Pharmaceuticals, Inc. Q2 Income From Operations USD -32.556 Million Vs. IBES Estimate USD -24.6 Million
- BRIEF-SUNation Energy, Inc Q2 Gross Profit USD 2.1 Million
- BRIEF-TScan Therapeutics Q2 Net Income USD -30.359 Million
- Performance Food Group 4Q Adj EPS $1.59 >PFGC
- Humacyte 2Q Loss/Shr 16c >HUMA
- 908 Devices CEO, CFO to present at Midwest IDEAS Investor Conference
- Mercia Fund Management cuts Northern 2 VCT annual fee to 2% of NAV from Oct. 1
- AURA BIOSCIENCES, INC. : LEERINK PARTNERS CUTS TARGET PRICE TO $12 FROM $17
- US MBA Mortgage Survey Snapshot
- US MBA Mortgage Survey Of Current Interest Rates
- Performance Food Group 4Q EPS $1.03 >PFGC
- Performance Food Group 4Q Net $162.3M >PFGC
- Performance Food Group 4Q Sales $18.03B >PFGC
- Metro Inc 3Q Food Same-Store Sales Down 1.5% >MRU.T
- Hydro One 2Q EPS C$0.62 >H.T
- Metaplanet started moving BTC; Is a sale coming?
- New data display features added to the futures elite trader homepage
- CFD profit share feature upgraded for safer earnings
